|
THAP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.355200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.434590E-01 |
| Normal-vs-Stage2 |
9.632800E-01 |
| Normal-vs-Stage3 |
6.842200E-01 |
| Normal-vs-Stage4 |
4.700800E-01 |
| Stage1-vs-Stage2 |
5.140000E-01 |
| Stage1-vs-Stage3 |
6.939600E-01 |
| Stage1-vs-Stage4 |
1.384220E-01 |
| Stage2-vs-Stage3 |
8.239600E-01 |
| Stage2-vs-Stage4 |
5.269600E-01 |
| Stage3-vs-Stage4 |
3.498000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.365800E-01 |
| Normal-vs-AfricanAmerican |
6.249600E-01 |
| Normal-vs-Asian |
5.176000E-01 |
| Caucasian-vs-AfricanAmerican |
7.864000E-01 |
| Caucasian-vs-Asian |
5.956200E-01 |
| AfricanAmerican-vs-Asian |
6.811200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.976200E-01 |
| Normal-vs-Female |
6.471600E-01 |
| Male-vs-Female |
8.712400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.407600E-01 |
| Normal-vs-Extreme_Weight |
1.223040E-01 |
| Normal-vs-Obese |
4.749200E-01 |
| Normal-vs-Extreme_Obese |
8.504200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.043400E-01 |
| Normal_Weight-vs-Obese |
1.264000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.518200E-01 |
| Extreme_Weight-vs-Obese |
6.813600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.723400E-01 |
| Obese-vs-Extreme_Obese |
8.788600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.410550E-01 |
| Normal-vs-Age(41-60Yrs) |
3.552800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.174200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.933600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.171800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.773000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.714200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.668400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.483800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.013400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.679200E-01 |
| Normal-VS-Type2 PRCC |
2.158800E-01 |
| Normal-VS-KIRP CIMP |
4.422200E-04 |
| Normal-VS-Unclassified PRCC |
6.634400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.341900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.062500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.266400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.688190E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.717200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.862200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.709600E-01 |
| Normal-vs-N1 |
4.711400E-01 |
| Normal-vs-N2 |
6.842800E-01 |
| N0-vs-N1 |
2.290600E-01 |
| N0-vs-N2 |
8.870800E-01 |
| N1-vs-N2 |
6.642200E-01 |
|
|
